Cargando…

Development of the Thalassaemia Adult Life Index (ThALI)

BACKGROUND: Beta Thalassaemia Major (βTM) is a chronic genetic illness whereby the challenges faced by patients exposes them to increased risk of psychosocial issues. Despite this, a disease-specific tool to measure the impact of this illness on adult patients has yet to be developed. METHODS: In co...

Descripción completa

Detalles Bibliográficos
Autores principales: Kantaris, Xenya, Shevlin, Mark, Porter, John, Myers, Lynn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291498/
https://www.ncbi.nlm.nih.gov/pubmed/32532297
http://dx.doi.org/10.1186/s12955-020-01437-6
_version_ 1783545918952308736
author Kantaris, Xenya
Shevlin, Mark
Porter, John
Myers, Lynn
author_facet Kantaris, Xenya
Shevlin, Mark
Porter, John
Myers, Lynn
author_sort Kantaris, Xenya
collection PubMed
description BACKGROUND: Beta Thalassaemia Major (βTM) is a chronic genetic illness whereby the challenges faced by patients exposes them to increased risk of psychosocial issues. Despite this, a disease-specific tool to measure the impact of this illness on adult patients has yet to be developed. METHODS: In collaboration with βTM adult patients, this study aimed to develop a comprehensive, disease-specific, easy to use psychometrically sound tool to measure the impact of chelation and transfusion dependent βTM in a cross-cultural patient group in England.The Thalassaemia Life Index (ThALI) was developed in two stages – item generation and pre-testing and item reduction – in collaboration with service users. Recruited adult patients shaped the design of the instrument including its statements and subscales. Standard item reduction techniques were used to develop the instrument. RESULTS: The final version of the ThALI encompasses 35 statements and five sub-scales - general physical health, coping, body image, appearance and confidence, social relationships and autonomy. This endorses the multidimensionality of quality of life (QoL). The factor structure of the ThALI is highly stable and its internal consistency is high (alpha = 0.87 for the overall scale; 0.83–0.94 for its subscales). The ThALI has sound scaling assumptions, acceptability and score variability. Content validity was confirmed by experts and service user interviewees. The loadings for the items retained were adequate and the item discriminant validity sound. CONCLUSIONS: The ThALI covers the impact of βTM in adult patients. Preliminary testing shows its multidimensionality to be reliable and valid. The national authentication of the tool with patients treated in Centres of Excellence will aim to provide further evidence regarding the ThALI’s psychometric properties. Once authenticated, the ThALI may be utilised in research and in clinical settings to assess the effects of new therapies and/or interventions from the patients’ perspective to inform practice and/or to identify areas of concern.
format Online
Article
Text
id pubmed-7291498
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72914982020-06-12 Development of the Thalassaemia Adult Life Index (ThALI) Kantaris, Xenya Shevlin, Mark Porter, John Myers, Lynn Health Qual Life Outcomes Research BACKGROUND: Beta Thalassaemia Major (βTM) is a chronic genetic illness whereby the challenges faced by patients exposes them to increased risk of psychosocial issues. Despite this, a disease-specific tool to measure the impact of this illness on adult patients has yet to be developed. METHODS: In collaboration with βTM adult patients, this study aimed to develop a comprehensive, disease-specific, easy to use psychometrically sound tool to measure the impact of chelation and transfusion dependent βTM in a cross-cultural patient group in England.The Thalassaemia Life Index (ThALI) was developed in two stages – item generation and pre-testing and item reduction – in collaboration with service users. Recruited adult patients shaped the design of the instrument including its statements and subscales. Standard item reduction techniques were used to develop the instrument. RESULTS: The final version of the ThALI encompasses 35 statements and five sub-scales - general physical health, coping, body image, appearance and confidence, social relationships and autonomy. This endorses the multidimensionality of quality of life (QoL). The factor structure of the ThALI is highly stable and its internal consistency is high (alpha = 0.87 for the overall scale; 0.83–0.94 for its subscales). The ThALI has sound scaling assumptions, acceptability and score variability. Content validity was confirmed by experts and service user interviewees. The loadings for the items retained were adequate and the item discriminant validity sound. CONCLUSIONS: The ThALI covers the impact of βTM in adult patients. Preliminary testing shows its multidimensionality to be reliable and valid. The national authentication of the tool with patients treated in Centres of Excellence will aim to provide further evidence regarding the ThALI’s psychometric properties. Once authenticated, the ThALI may be utilised in research and in clinical settings to assess the effects of new therapies and/or interventions from the patients’ perspective to inform practice and/or to identify areas of concern. BioMed Central 2020-06-12 /pmc/articles/PMC7291498/ /pubmed/32532297 http://dx.doi.org/10.1186/s12955-020-01437-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kantaris, Xenya
Shevlin, Mark
Porter, John
Myers, Lynn
Development of the Thalassaemia Adult Life Index (ThALI)
title Development of the Thalassaemia Adult Life Index (ThALI)
title_full Development of the Thalassaemia Adult Life Index (ThALI)
title_fullStr Development of the Thalassaemia Adult Life Index (ThALI)
title_full_unstemmed Development of the Thalassaemia Adult Life Index (ThALI)
title_short Development of the Thalassaemia Adult Life Index (ThALI)
title_sort development of the thalassaemia adult life index (thali)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291498/
https://www.ncbi.nlm.nih.gov/pubmed/32532297
http://dx.doi.org/10.1186/s12955-020-01437-6
work_keys_str_mv AT kantarisxenya developmentofthethalassaemiaadultlifeindexthali
AT shevlinmark developmentofthethalassaemiaadultlifeindexthali
AT porterjohn developmentofthethalassaemiaadultlifeindexthali
AT myerslynn developmentofthethalassaemiaadultlifeindexthali